Innospec Net Debt vs Accounts Payable Analysis

IOSP Stock  USD 129.50  0.07  0.05%   
Innospec financial indicator trend analysis is infinitely more than just investigating Innospec recent accounting drivers to predict future trends. We encourage investors to analyze account correlations over time for multiple indicators to determine whether Innospec is a good investment. Please check the relationship between Innospec Net Debt and its Accounts Payable accounts. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.

Net Debt vs Accounts Payable

Net Debt vs Accounts Payable Correlation Analysis

The overlapping area represents the amount of trend that can be explained by analyzing historical patterns of Innospec Net Debt account and Accounts Payable. At this time, the significance of the direction appears to have significant contrarian relationship.
The correlation between Innospec's Net Debt and Accounts Payable is -0.42. Overlapping area represents the amount of variation of Net Debt that can explain the historical movement of Accounts Payable in the same time period over historical financial statements of Innospec, assuming nothing else is changed. The correlation between historical values of Innospec's Net Debt and Accounts Payable is a relative statistical measure of the degree to which these accounts tend to move together. The correlation coefficient measures the extent to which Net Debt of Innospec are associated (or correlated) with its Accounts Payable. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when Accounts Payable has no effect on the direction of Net Debt i.e., Innospec's Net Debt and Accounts Payable go up and down completely randomly.

Correlation Coefficient

-0.42
Relationship DirectionNegative 
Relationship StrengthVery Weak

Net Debt

The total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds.

Accounts Payable

An accounting item on the balance sheet that represents Innospec obligation to pay off a short-term debt to its creditors. The accounts payable entry is usually reported under current liabilities. If accounts payable of Innospec are not paid within the agreed terms, the payables are considered to be in default, which may trigger a penalty or interest payment, or the revocation of additional credit from the supplier. Accounts payable may also be considered a source of cash, since they represent funds being borrowed from suppliers. Given these cash flow considerations, suppliers have a natural inclination to push for shorter payment terms, while creditors want to lengthen the payment terms. The amount a company owes to suppliers or vendors for products or services received but not yet paid for. It represents the company's short-term liabilities.
Most indicators from Innospec's fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Innospec current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.At this time, Innospec's Selling General Administrative is relatively stable compared to the past year. As of 05/18/2024, Enterprise Value Over EBITDA is likely to grow to 14.38, while Tax Provision is likely to drop slightly above 43.6 M.
 2021 2022 2023 2024 (projected)
Gross Profit434.9M586.7M582.8M318.7M
Total Revenue1.5B2.0B1.9B2.0B

Innospec fundamental ratios Correlations

-0.090.840.910.840.81-0.340.790.890.580.930.110.560.790.010.310.87-0.260.40.830.530.77-0.02-0.210.360.36
-0.09-0.41-0.26-0.39-0.280.91-0.47-0.26-0.370.150.18-0.38-0.350.480.87-0.39-0.020.090.41-0.34-0.430.540.84-0.51-0.51
0.84-0.410.890.750.62-0.580.750.80.570.650.020.570.7-0.09-0.090.94-0.280.220.530.410.75-0.34-0.440.540.54
0.91-0.260.890.80.79-0.450.750.970.570.760.340.550.830.070.060.93-0.250.550.720.560.810.07-0.250.240.24
0.84-0.390.750.80.96-0.660.980.760.840.750.120.820.95-0.430.00.76-0.050.410.610.830.96-0.1-0.470.360.37
0.81-0.280.620.790.96-0.540.920.770.760.760.320.740.94-0.30.050.69-0.050.570.630.880.910.14-0.340.150.16
-0.340.91-0.58-0.45-0.66-0.54-0.73-0.42-0.72-0.090.09-0.72-0.60.570.72-0.55-0.07-0.070.14-0.61-0.70.490.85-0.55-0.56
0.79-0.470.750.750.980.92-0.730.710.860.660.030.860.93-0.54-0.090.760.040.30.510.830.97-0.24-0.580.480.49
0.89-0.260.80.970.760.77-0.420.710.50.730.320.480.820.080.080.9-0.170.540.710.550.780.1-0.270.250.24
0.58-0.370.570.570.840.76-0.720.860.50.430.121.00.78-0.52-0.150.550.170.310.350.830.88-0.16-0.50.360.37
0.930.150.650.760.750.76-0.090.660.730.430.10.410.680.080.540.66-0.330.410.90.460.620.140.030.170.17
0.110.180.020.340.120.320.090.030.320.120.10.110.250.450.010.09-0.030.850.260.350.180.810.41-0.7-0.7
0.56-0.380.570.550.820.74-0.720.860.481.00.410.110.77-0.54-0.160.540.190.30.340.820.87-0.18-0.50.370.38
0.79-0.350.70.830.950.94-0.60.930.820.780.680.250.77-0.40.010.760.070.490.640.860.970.02-0.410.270.28
0.010.48-0.090.07-0.43-0.30.57-0.540.08-0.520.080.45-0.54-0.40.29-0.09-0.410.340.15-0.45-0.480.570.66-0.51-0.52
0.310.87-0.090.060.00.050.72-0.090.08-0.150.540.01-0.160.010.29-0.05-0.050.120.72-0.12-0.090.370.66-0.22-0.22
0.87-0.390.940.930.760.69-0.550.760.90.550.660.090.540.76-0.09-0.05-0.20.280.580.440.79-0.24-0.490.520.52
-0.26-0.02-0.28-0.25-0.05-0.05-0.070.04-0.170.17-0.33-0.030.190.07-0.41-0.05-0.20.02-0.150.320.09-0.13-0.070.120.13
0.40.090.220.550.410.57-0.070.30.540.310.410.850.30.490.340.120.280.020.490.530.420.710.33-0.55-0.55
0.830.410.530.720.610.630.140.510.710.350.90.260.340.640.150.720.58-0.150.490.390.560.320.26-0.01-0.01
0.53-0.340.410.560.830.88-0.610.830.550.830.460.350.820.86-0.45-0.120.440.320.530.390.850.1-0.350.140.14
0.77-0.430.750.810.960.91-0.70.970.780.880.620.180.870.97-0.48-0.090.790.090.420.560.85-0.12-0.510.370.38
-0.020.54-0.340.07-0.10.140.49-0.240.1-0.160.140.81-0.180.020.570.37-0.24-0.130.710.320.1-0.120.69-0.9-0.9
-0.210.84-0.44-0.25-0.47-0.340.85-0.58-0.27-0.50.030.41-0.5-0.410.660.66-0.49-0.070.330.26-0.35-0.510.69-0.76-0.76
0.36-0.510.540.240.360.15-0.550.480.250.360.17-0.70.370.27-0.51-0.220.520.12-0.55-0.010.140.37-0.9-0.761.0
0.36-0.510.540.240.370.16-0.560.490.240.370.17-0.70.380.28-0.52-0.220.520.13-0.55-0.010.140.38-0.9-0.761.0
Click cells to compare fundamentals

Innospec Account Relationship Matchups

Innospec fundamental ratios Accounts

201920202021202220232024 (projected)
Total Assets1.5B1.4B1.6B1.6B1.7B1.0B
Short Long Term Debt Total92.6M40.8M35.6M45.3M45.2M42.9M
Other Current Liab169.9M141.9M175.4M226.6M191.5M109.6M
Total Current Liabilities303.5M252.4M336.6M405.8M371.5M233.9M
Total Stockholder Equity918.9M944.9M1.0B1.0B1.1B1.2B
Property Plant And Equipment Net231.1M250.9M249.8M266.2M313.4M329.1M
Net Debt16.9M(64.5M)(106.2M)(101.8M)(158.5M)(150.6M)
Retained Earnings755.5M758.6M822.9M924.2M1.0B1.1B
Accounts Payable122M98.7M148.7M165.3M163.6M88.4M
Cash75.7M105.3M141.8M147.1M203.7M213.9M
Non Current Assets Total838.5M831.2M842.8M731.1M821.7M601.2M
Non Currrent Assets Other5.9M8.2M5M55.2M41.3M32.5M
Cash And Short Term Investments75.7M105.3M141.8M147.1M203.7M213.9M
Net Receivables292M221.4M284.5M334.6M359.8M377.8M
Common Stock Shares Outstanding24.7M24.8M24.9M25.0M25.0M20.1M
Liabilities And Stockholders Equity1.5B1.4B1.6B1.6B1.7B1.0B
Non Current Liabilities Total246.4M200.1M201.3M157.5M186.3M170.8M
Inventory244.6M220M277.6M373.1M300.1M169.6M
Other Current Assets1.1M13.1M800K400K22.1M23.2M
Other Stockholder Equity237.5M243.3M256.7M261.1M266.7M258.5M
Total Liab549.9M452.5M537.9M563.3M557.8M468.7M
Property Plant And Equipment Gross231.1M250.9M249.8M266.2M637.4M669.3M
Total Current Assets630.3M566.2M728.1M872.6M885.7M930.0M
Accumulated Other Comprehensive Income(74.4M)(57.3M)(46.9M)(145.2M)(148.1M)(140.7M)
Short Term Debt11.6M11.8M12.5M13.9M13.6M20.3M
Intangible Assets113.5M75.3M57.5M45M57.3M54.4M
Other Liab165.4M171.1M178.2M126.1M145.0M101.8M
Other Assets130.9M175M171.2M61.1M70.3M86.2M
Good Will363M371.2M364.3M358.8M399.3M304.3M
Property Plant Equipment198.7M210.8M249.8M220.9M254.0M266.7M
Net Tangible Assets463.9M526.8M611.2M634.2M729.3M765.8M
Retained Earnings Total Equity755.5M758.6M822.9M924.2M1.1B628.1M
Long Term Debt Total205.8M187.7M59.1M100K115K109.3K

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Innospec is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Innospec Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Innospec Stock. Highlighted below are key reports to facilitate an investment decision about Innospec Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Innospec. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in state.
To learn how to invest in Innospec Stock, please use our How to Invest in Innospec guide.
You can also try the Content Syndication module to quickly integrate customizable finance content to your own investment portal.

Complementary Tools for Innospec Stock analysis

When running Innospec's price analysis, check to measure Innospec's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Innospec is operating at the current time. Most of Innospec's value examination focuses on studying past and present price action to predict the probability of Innospec's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Innospec's price. Additionally, you may evaluate how the addition of Innospec to your portfolios can decrease your overall portfolio volatility.
Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Earnings Calls
Check upcoming earnings announcements updated hourly across public exchanges
Money Managers
Screen money managers from public funds and ETFs managed around the world
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Stocks Directory
Find actively traded stocks across global markets
Is Innospec's industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Innospec. If investors know Innospec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Innospec listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Quarterly Earnings Growth
0.241
Dividend Share
1.41
Earnings Share
5.88
Revenue Per Share
77.969
Quarterly Revenue Growth
(0.02)
The market value of Innospec is measured differently than its book value, which is the value of Innospec that is recorded on the company's balance sheet. Investors also form their own opinion of Innospec's value that differs from its market value or its book value, called intrinsic value, which is Innospec's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Innospec's market value can be influenced by many factors that don't directly affect Innospec's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Innospec's value and its price as these two are different measures arrived at by different means. Investors typically determine if Innospec is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Innospec's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.